This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: Gw Research Limited, Royal Holloway and Bedford New College. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: Innovations of Robin Williams in Cannabinoid Research
Introduction
Robin Williams is an accomplished inventor based in Egham, GB. He has made significant contributions to the field of cannabinoid research, particularly in the treatment of epilepsy. With a total of three patents to his name, Williams has focused on the therapeutic applications of cannabidiolic acid (CBDA).
Latest Patents
Williams' latest patents revolve around the use of cannabinoids in the treatment of epilepsy. His inventions detail the use of a therapeutically effective amount of CBDA, specifically targeting generalized seizures, including tonic-clonic seizures. The patents emphasize the importance of using a highly purified extract of cannabis, with CBDA content exceeding 60%, and ideally greater than 98% of the total extract. The patents also highlight the removal of other cannabinoids, such as tetrahydrocannabinol (THC) or tetrahydrocannabinol acid (THCA), to enhance the therapeutic efficacy of the treatment. Additionally, the CBDA may also be synthetically produced, providing further avenues for research and application.
Career Highlights
Throughout his career, Williams has worked with notable organizations, including GW Research Limited and Royal Holloway and Bedford New College. His work in these institutions has allowed him to explore the potential of cannabinoids in medical applications, contributing to the growing body of research in this area.
Collaborations
Williams has collaborated with esteemed colleagues, including Colin Stott and Benjamin Whalley. These partnerships have facilitated the advancement of his research and the development of innovative solutions in cannabinoid therapy.
Conclusion
Robin Williams stands out as a key figure in cannabinoid research, particularly for his innovative approaches to treating epilepsy. His patents reflect a commitment to advancing medical science through the exploration of cannabinoids. The impact of his work continues to resonate within the field, paving the way for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile